phase readout
saveNCT00862992: Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Tanabe Pharma Corporation. Phase: PHASE2. Conditions: Schizophrenia
view source ↗
comments(0)
5-min edit window · permanent after that